Cargando…

GCase Enhancers: A Potential Therapeutic Option for Gaucher Disease and Other Neurological Disorders

Pharmaceutical chaperones (PCs) are small compounds able to bind and stabilize misfolded proteins, allowing them to recover their native folding and thus their biological activity. In particular, lysosomal storage disorders (LSDs), a class of metabolic disorders due to genetic mutations that result...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martínez-Bailén, Macarena, Clemente, Francesca, Matassini, Camilla, Cardona, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325019/ https://www.ncbi.nlm.nih.gov/pubmed/35890122 http://dx.doi.org/10.3390/ph15070823

Ejemplares similares

Piperidine Azasugars Bearing Lipophilic Chains: Stereoselective Synthesis and Biological Activity as Inhibitors of Glucocerebrosidase (GCase)
por: Clemente, Francesca, et al.
Publicado: (2021)

Synthesis of “All-Cis” Trihydroxypiperidines from a Carbohydrate-Derived Ketone: Hints for the Design of New β-Gal and GCase Inhibitors
por: Davighi, Maria Giulia, et al.
Publicado: (2020)

3,4,5‐Trihydroxypiperidine Based Multivalent Glucocerebrosidase (GCase) Enhancers
por: Vanni, Costanza, et al.
Publicado: (2022)

Stereoselective Synthesis of Heavily Hydroxylated Azepane Iminosugars via Osmium-Catalyzed Tethered Aminohydroxylation
por: Martínez-Bailén, Macarena, et al.
Publicado: (2023)

Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
por: Clemente, Francesca, et al.
Publicado: (2022)

Brain-penetrant heat shock protein amplifier arimoclomol enhances GCase activity in in vitro Gaucher disease models
por: Hettinghouse, Aubryanna, et al.
Publicado: (2018)

New Frontiers on Human Safe Insecticides and Fungicides: An Opinion on Trehalase Inhibitors
por: Matassini, Camilla, et al.
Publicado: (2020)

Women in Bioorganic Chemistry
por: Cardona, Francesca, et al.
Publicado: (2022)

GCase and LIMP2 Abnormalities in the Liver of Niemann Pick Type C Mice
por: van der Lienden, Martijn J. C., et al.
Publicado: (2021)

Clinical Sphingolipids Pathway in Parkinson’s Disease: From GCase to Integrated-Biomarker Discovery
por: Esfandiary, Ali, et al.
Publicado: (2022)

Current Therapeutic Options for Heart Failure in Elderly Patients
por: Guerra, F., et al.
Publicado: (2017)

Early GCase activity is a predictor of long-term cognitive decline in Parkinson’s disease
por: Oftedal, Linn, et al.
Publicado: (2023)

Are There Neurological Symptoms in Type 1 of Gaucher Disease?
por: ALAEI, Mohammadreza, et al.
Publicado: (2018)

The Spectrum of Neurological Manifestations Associated with Gaucher Disease
por: Roshan Lal, Tamanna, et al.
Publicado: (2017)

The Spectrum of Neurological and Sensory Abnormalities in Gaucher Disease Patients: A Multidisciplinary Study (SENOPRO)
por: Tullo, Maria Giulia, et al.
Publicado: (2023)

Allyl Cyanate/Isocyanate Rearrangement in Glycals: Stereoselective Synthesis of 1-Amino and Diamino Sugar Derivatives
por: Mirabella, Stefania, et al.
Publicado: (2020)

The Saccadic and Neurological Deficits in Type 3 Gaucher Disease
por: Benko, William, et al.
Publicado: (2011)

Exploring architectures displaying multimeric presentations of a trihydroxypiperidine iminosugar
por: Matassini, Camilla, et al.
Publicado: (2015)

An Intramolecular Hydroaminomethylation-Based Approach to Pyrrolizidine Alkaloids under Microwave-Assisted Heating
por: Petricci, Elena, et al.
Publicado: (2022)

Gaucher Disease: New Expanded Classification Emphasizing Neurological Features
por: ALAEI, Mohammad Reza, et al.
Publicado: (2019)

LRRK2 kinase activity regulates GCase level and enzymatic activity differently depending on cell type in Parkinson’s disease
por: Kedariti, Maria, et al.
Publicado: (2022)

Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease
por: Wei, Jianshe, et al.
Publicado: (2021)

Gaucher disease – therapeutic aspects in Romania
por: Chis, Bogdan Augustin, et al.
Publicado: (2021)

Gaucher Disease and Gaucher Cells
por: Gözdaşoğlu, Sevgi
Publicado: (2015)

Dermal fibroblasts from patients with Parkinson’s disease have normal GCase activity and autophagy compared to patients with PD and GBA mutations
por: Collins, Lucy M, et al.
Publicado: (2018)

Induction of the type I interferon response in neurological forms of Gaucher disease
por: Vitner, Einat B., et al.
Publicado: (2016)

Gaucher disease: clinical profile and therapeutic developments
por: Cox, Timothy M
Publicado: (2010)

Probing the Influence of Linker Length and Flexibility in the Design and Synthesis of New Trehalase Inhibitors
por: D’Adamio, Giampiero, et al.
Publicado: (2018)

Frontiers in therapeutic development of allopregnanolone for Alzheimer’s disease and other neurological disorders
por: Irwin, Ronald W., et al.
Publicado: (2014)

Oculomotor and Vestibular Findings in Gaucher Disease Type 3 and Their Correlation with Neurological Findings
por: Bremova-Ertl, Tatiana, et al.
Publicado: (2018)

Atypical Antipsychotics and Other Therapeutic Options for Treatment of Resistant Major Depressive Disorder
por: Seo, Rubo J., et al.
Publicado: (2010)

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations
por: Labrador-Garrido, Adahir, et al.
Publicado: (2023)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism
por: Furderer, Makaila L., et al.
Publicado: (2022)

Gaucher's disease
por: Bohra, Vijay, et al.
Publicado: (2011)

Gaucher’s Disease
Publicado: (1916)

Transcranial Magnetic Stimulation as a Therapeutic Option for Neurologic Diseases and Psychiatric Disorders: A Systematic Review
por: Ozturk, Huseyin, et al.
Publicado: (2022)

Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
por: Rosenbloom, Barry E., et al.
Publicado: (2022)

Editorial: Natural Products-Based Drugs: Potential Therapeutics Against Alzheimer’s Disease and Other Neurological Disorders
por: Ayaz, Muhammad, et al.
Publicado: (2019)

Toward a Novel Therapeutic Option for Polycythemia
por: Vinchi, Francesca
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_40d1cln6m9ae159229rf4rk5au